Showing 2776 results
-
In The News /Novartis Chairman Joerg Reinhardt says the successful fight against infectious diseases in poor countries provides valuable lessons for the emerging crisis of chronic diseases.
-
In The News /Humanosphere highlights the work Novartis Access is doing to find a social enterprise solution to help patients in lower-income countries get access to medicines for chronic diseases.
-
Featured News /
-
Featured News /
-
Story /Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
-
Story /The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
-
Story /Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
-
Story /An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.
-
Story /Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
-
Story /New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.